Chief Accounting Officer · Ocugen, Inc. (OCGN)

Ramesh Ramachandran

FY2025 is the first fiscal year CompBrief holds for Ramesh Ramachandran as a named executive officer of Ocugen; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,192,089

6th of 6 named executive officers at Ocugen by FY2025 total.

6 named officers on file for Ocugen, FY2025

See an example →

What this number hides

The filing gives the total. Ocugen’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how Ocugen’s whole pay program stands against its peers

  • Ocugen’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OCGN→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2026 (DEF 14A).

Free

Get Ramesh Ramachandran’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Ramesh Ramachandran and every company like it: Velarion Intel, free for 3 days, no card →

Ramesh Ramachandran compensation by year

Ocugen Summary Compensation Table · the one fiscal year held
In US dollars, as Ocugen reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2025
Salary$360,500
Bonus$137,927
Stock awards$420,455
Option awards$266,708
Non-equity incentive$0
Pension and deferred compensation$0
All other$6,498
Total$1,192,089

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ocugen, Inc. DEF 14A filed April 28, 2026, accession 0001140361-26-017260, and prior-year filings.

How this page was built: the Ocugen, Inc. filed document, accession 0001140361-26-017260. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU266,111$359,250—
Option199,349—$0.90
Option103,064—$1.17
Option150,797—$0.90

Per the Outstanding Equity Awards at Fiscal Year-End table in Ocugen, Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Ocugen’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
Shankar MusunuriChief Executive Officer, Chairman and Co-Founder$4,841,822
Huma QamarChief Medical Officer$2,888,481
Huma CMIChief Medical Officer$2,888,481
Arun UpadhyayChief Scientific Officer$2,136,069
Ramesh CMAChief Accounting Officer$1,192,089
Ramesh Ramachandran · this pageChief Accounting Officer$1,192,089

Ramesh Ramachandran's compensation dossier, Ocugen

You have read Ramesh Ramachandran's totals and holdings. The dossier adds each equity grant Ocugen disclosed for Ramesh Ramachandran and Ocugen's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full Ocugen compensation record

free company brief

This page is one person within Ocugen's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Ocugen's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Ocugen's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Ramesh Ramachandran's compensation dossier